0
Skip to Content
CuriousKocab
About
Blog
Sponsor
Contact
CuriousKocab
About
Blog
Sponsor
Contact
About
Blog
Sponsor
Contact
Gene Therapy Basics
Science Notes Andrew Kocab 5/31/20 Science Notes Andrew Kocab 5/31/20

Gene Therapy Basics

Some background facts about an increasingly impactful therapeutic approach.

Read More
Thinking About Patents: Ashley Sloat, PhD
General Thoughts Andrew Kocab 5/18/20 General Thoughts Andrew Kocab 5/18/20

Thinking About Patents: Ashley Sloat, PhD

Learning about patents and patentability from a patent agent.

Read More
Complimenting the Complement System
Science Notes Andrew Kocab 5/3/20 Science Notes Andrew Kocab 5/3/20

Complimenting the Complement System

Highlighting an often overlooked component of the immune system.

Read More
Drug Money: Michigan Therapeutics Companies & Financing 2009-2019
General Thoughts Andrew Kocab 4/19/20 General Thoughts Andrew Kocab 4/19/20

Drug Money: Michigan Therapeutics Companies & Financing 2009-2019

A second dive into the Michigan drug development ecosystem.

Read More
Notes on the Coronavirus
Science Notes Andrew Kocab 3/21/20 Science Notes Andrew Kocab 3/21/20

Notes on the Coronavirus

The coronavirus is dominating the news. Here are some notes on the virus, including how it’s thought to infect us and what researchers are doing to fight it.

Read More
Designing a Better Cancer Drug: Mekanistic Therapeutics, LLC
Start Up Andrew Kocab 2/22/20 Start Up Andrew Kocab 2/22/20

Designing a Better Cancer Drug: Mekanistic Therapeutics, LLC

Michigan startup that’s designing a better cancer drug.

Read More
Drug Money: NIH Grant Funding for Therapeutics Companies in Michigan 2009-2019
General Thoughts Andrew Kocab 2/3/20 General Thoughts Andrew Kocab 2/3/20

Drug Money: NIH Grant Funding for Therapeutics Companies in Michigan 2009-2019

A dive into NIH grant award data to gain insight into the ecosystem for Michigan-based therapeutics companies.

Read More
Drug Discovery in Academia: Karson Kump
Scientist Andrew Kocab 11/7/19 Scientist Andrew Kocab 11/7/19

Drug Discovery in Academia: Karson Kump

Karson targets the Bcl-2 protein family to design and develop new drugs for cancer.

Read More
First First-in-Human: Reflections on a Milestone
General Thoughts Andrew Kocab 10/24/19 General Thoughts Andrew Kocab 10/24/19

First First-in-Human: Reflections on a Milestone

ONL Therapeutics recently achieved a milestone. This was also a milestone in my career, one that had more emotional impact than I expected.

Read More
Older Posts

Copyright © 2024 Kocab Enterprises, LLC. All rights reserved.

Powered by Squarespace